Stay updated on MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial
Sign up to get notified when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.

Latest updates to the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page
- Check5 days agoChange DetectedA banner announces an NIH website terminology transition, and the site revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site revision shown in the footer changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page update removes key study documents and record details (examples include Informed Consent Form and Study Protocol), as well as related links and metadata, affecting visibility of consent materials and the study's documentation history.SummaryDifference19%

- Check40 days agoChange DetectedThe page shows a revision tag updated from v3.6.6 to v3.7.0. This indicates a system or content update was applied.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing v3.6.5, indicating a small update to the page’s build or documentation rather than substantive content changes.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page's revision identifier was updated from v3.6.4 to v3.6.5, indicating a small update to the page's documentation or backend; no visible changes to study details are indicated.SummaryDifference0.1%

Stay in the know with updates to MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.